Columbus Macro, LLC Gilead Sciences, Inc. Transaction History

Columbus Macro, LLC

$830 Million
Q3 2025

A detailed history of Columbus Macro, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Columbus Macro, LLC holds 23,966 shares of GILD stock, worth $2.95 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

23,966

Previous 24,486 2.12%

Holding current value

$2.95 Million

Previous $2.71 Million 1.99%

% of portfolio

0.32%

Previous 0.35%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	SELL	$108.22 - $120.47 $56,274 - $62,644	-520 Reduced 2.12%	23,966 $2.66 Million
Q2 2025 Jul 23, 2025	BUY	$96.91 - $113.0 $45,353 - $52,884	468 Added 1.95%	24,486 $2.71 Million
Q1 2025 Apr 17, 2025	SELL	$89.14 - $117.41 $96,716 - $127,389	-1,085 Reduced 4.32%	24,018 $2.69 Million
Q4 2024 Jan 24, 2025	BUY	$83.95 - $97.9 $755,885 - $881,491	9,004 Added 55.93%	25,103 $2.32 Million
Q3 2024 Oct 18, 2024	SELL	$66.59 - $83.99 $22,906 - $28,892	-344 Reduced 2.09%	16,099 $1.35 Million
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $42,184 - $48,683	668 Added 4.23%	16,443 $1.13 Million
Q1 2024 Apr 12, 2024	SELL	$71.58 - $87.29 $57,765 - $70,443	-807 Reduced 4.87%	15,775 $1.16 Million
Q4 2023 Jan 19, 2024	BUY	$73.27 - $83.09 $1.21 Million - $1.38 Million	16,582 New	16,582 $1.34 Million
Q4 2021 Jan 21, 2022	SELL	$64.88 - $73.64 $1.29 Million - $1.46 Million	-19,881 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $40,140 - $43,306	-593 Reduced 2.9%	19,881 $1.39 Million
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $16,057 - $17,545	-253 Reduced 1.22%	20,474 $1.41 Million
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $212,340 - $242,279	-3,539 Reduced 14.58%	20,727 $1.34 Million
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $92,282 - $105,151	-1,629 Reduced 6.29%	24,266 $1.41 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $500,277 - $629,012	-8,056 Reduced 23.73%	25,895 $1.64 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $134,986 - $156,744	-1,866 Reduced 5.21%	33,951 $2.61 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $184,132 - $235,846	-2,940 Reduced 7.59%	35,817 $2.68 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $646,024 - $710,605	-10,484 Reduced 21.29%	38,757 $2.52 Million
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $1.39 Million - $1.53 Million	-22,176 Reduced 31.05%	49,241 $3.12 Million
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $46,464 - $52,104	-751 Reduced 1.04%	71,417 $4.83 Million
Q1 2019 Apr 22, 2019	BUY	$62.53 - $70.05 $97,109 - $108,787	1,553 Added 2.2%	72,168 $4.69 Million
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $74,585 - $97,328	1,232 Added 1.78%	70,615 $4.42 Million
Q3 2018 Oct 12, 2018	BUY	$71.28 - $78.92 $425,470 - $471,073	5,969 Added 9.41%	69,383 $5.36 Million
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $4.11 Million - $4.8 Million	63,414 New	63,414 $4.49 Million

Others Institutions Holding GILD

# of Institutions

2,328

Shares Held

1.02B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $154B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Columbus Macro, LLC with notifications on news.

Account

Columbus Macro, LLC Gilead Sciences, Inc. Transaction History